Key takeaways
Lantus (insulin glargine) and NovoLog (insulin aspart) are both insulins used to manage blood sugar levels in people with Type 1 and Type 2 diabetes. However, they belong to different classes of insulin. Lantus is a long-acting insulin, typically injected once daily, while NovoLog is a fast-acting insulin, usually taken multiple times a day before meals. Lantus is available as a vial and a prefilled pen, whereas NovoLog comes in vials and various prefilled pen options. Both medications can cause low blood sugar and weight gain as possible side effects. Both medications have a brand-name and generic form available. NovoLog can be used in insulin pumps whereas Lantus is not used in insulin pumps. Both medications require careful monitoring of blood sugar levels and should not be shared to avoid infections.
